Zymewire Blog

Exploring the frontiers of biotech & pharma.

Join us as we dive into the sea of emerging biotechs, discuss industry news and the implications they have on providers to biopharma (CROs, CDMOs, eClinical, etc.), and tips for prospecting within the everchanging world of life sciences. 

OUR LATEST

Zymewire Blog

Preparing for CPhI: Drug Sponsor Overview

12 Oct, 2023
Road to Barcelona Read More

Recent Posts

World Alzheimer's Day: Cracking the Code
World Alzheimer's Day: Cracking the Code
21 Sep, 2023
Health & Science Days
by Alec de la Durantaye

A Growing Challenge

Read More
The IRA Effect: How the Inflation Reduction Act Will Reshape Behaviors in Biopharma
The IRA Effect: How the Inflation Reduction Act Will Reshape Behaviors in Biopharma
15 Sep, 2023
Industry Articles
by Alec de la Durantaye

The IRA: What is it? Signed into law in August 2022, the Inflation Reduction Act (IRA) was designed to fight inflation, invest in domestic ...

Read More
World Lung Cancer Day: Spotlight on Innovators
World Lung Cancer Day: Spotlight on Innovators
01 Aug, 2023
Health & Science Days
by Alec de la Durantaye

Conquering a Giant As the world comes together to observe World Lung Cancer Day, Zymewire sheds light on the ongoing efforts of biotech and ...

Read More
Discovering Kate Therapeutics
Discovering Kate Therapeutics
10 Jul, 2023
Discovering Biotech Startups
by Alec de la Durantaye

Building partnerships in our fast-paced industry requires timing and context so that service providers can align their offerings with the ...

Read More
A Letter to the COVID Collaborators
A Letter to the COVID Collaborators
13 Jun, 2023
Zymewire News
by Alec de la Durantaye

Thinking back to the first half of 2020 often causes a mixed wave of emotions to resurface. At the time, society as a whole shared an ...

Read More
Inside BIO 2023: Uncovering the Biopharma Landscape
Inside BIO 2023: Uncovering the Biopharma Landscape
30 May, 2023
Industry Articles
by Alec de la Durantaye

Countdown to Boston

Read More
Beyond Boundaries: Biotechs Spearheading the Fight Against HIV
Beyond Boundaries: Biotechs Spearheading the Fight Against HIV
18 May, 2023
Health & Science Days
by Alec de la Durantaye

Path to an HIV-Free World

Read More
Meet the Disruptors: Biotechs Transforming Gene Therapy on DNA Day
Meet the Disruptors: Biotechs Transforming Gene Therapy on DNA Day
25 Apr, 2023
Health & Science Days
by Alec de la Durantaye

A Tribute to the Pioneers DNA Day is an annual celebration to commemorate James Watson, Francis Crick, and Rosalind Franklin’s discovery ...

Read More
Navigating the Aftermath: What Lies Ahead for Biopharma Following the Collapse of SVB
Navigating the Aftermath: What Lies Ahead for Biopharma Following the Collapse of SVB
30 Mar, 2023
Industry Articles
by Alec de la Durantaye

Crisis Averted?

Read More
World Kidney Day 2023: Emerging Biopharma on the Hunt for a Cure
World Kidney Day 2023: Emerging Biopharma on the Hunt for a Cure
09 Mar, 2023
Health & Science Days
by Alec de la Durantaye

What’s the Deal with CKD?

Read More
Biopharma Funding Year in Review
Biopharma Funding Year in Review
26 Jan, 2023
Zymewire News
by Ian Hamilton-Burge, Director of Customer Solutions

Review of 2022 Biopharma funding: How should sales teams at service providers adapt for 2023?

Read More
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon
04 Jan, 2023
Zymewire News
by Alec de la Durantaye

Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon

Read More
Why Your Cold Outreach to Biotechs is Failing… And How to Fix It
Why Your Cold Outreach to Biotechs is Failing… And How to Fix It
25 Oct, 2022
Sales
by Danika Miller-Bouchard

When it comes to cold outreach in the B2B context, one thing is certain: Email is still the dominant channel. Sales professionals at ...

Read More
More Signal, Less Noise: Announcing Muting Companies in Zymewire
More Signal, Less Noise: Announcing Muting Companies in Zymewire
12 Oct, 2022
Zymewire News
by Ian Hamilton-Burge, Director of Customer Solutions

Noise is a Problem, Turn Down the Volume.

Read More
Reach your prospects the first time: Announcing improvements to Contact Search
Reach your prospects the first time: Announcing improvements to Contact Search
14 Feb, 2022
Zymewire News
by Ian Hamilton-Burge, Director of Customer Solutions

Laser-focused outreach outperforms generic messages and mass emails. That’s the guiding principle behind our update to Contact Search, ...

Read More
What’s the deal with NLP?
What’s the deal with NLP?
03 Dec, 2021
Industry Articles
by Ian Hamilton-Burge, Director of Customer Solutions

Machine learning. Artificial intelligence. Predictive analytics.

Read More
Scott’s Sales Tales: What Can Sales Pros Learn from a Hot Dog Eating Champ?
Scott’s Sales Tales: What Can Sales Pros Learn from a Hot Dog Eating Champ?
27 Oct, 2021
Sales
by Scott Ballenger

For those that are new to the “Sales Tales,” we launched a series of posts here on the Zymewire blog that capture some of my favorite sales ...

Read More
How the Heck to Find Your Way Around the Cell and Gene Therapy Space
How the Heck to Find Your Way Around the Cell and Gene Therapy Space
15 Oct, 2021
Industry Articles
by Team Zymewire

We know that the cell and gene therapy space is unique – and can be uniquely challenging to navigate, with specific quirks and nuances.

Read More
On the Virtual Road: Sales Tales with Scott Ballenger - Positioning
On the Virtual Road: Sales Tales with Scott Ballenger - Positioning
05 Oct, 2021
Sales
by Scott Ballenger

A few weeks ago, we launched a series of posts here on the Zymewire blog that encapsulate some of my favorite sales parables. In a ...

Read More
The Latest on Return to Business Travel
The Latest on Return to Business Travel
27 Sep, 2021
Industry Articles
by Team Zymewire

We had all hoped for far more certainty around travel this coming fall – but as the delta variant continues to wreak havoc around the ...

Read More
On the Virtual Road: Sales Tales with Scott Ballenger - One egg or two?
On the Virtual Road: Sales Tales with Scott Ballenger - One egg or two?
17 Sep, 2021
Sales
by Scott Ballenger

The pandemic has cost us many things, including, for too many of us, the ability to connect with our colleagues in person. At Zymewire, we ...

Read More
Remote Buying in a Virtual World: 6 Reflections from a Pharma Procurement Exec.
Remote Buying in a Virtual World: 6 Reflections from a Pharma Procurement Exec.
27 Aug, 2021
Industry Articles
by Team Zymewire

Recently, Zymewire’s Scott Ballenger had an opportunity to sit down with Stefanie Kuhner, an executive in the procurement department from ...

Read More
11 Insights to Help Build Great Partnerships with Cell & Gene Therapy Companies
11 Insights to Help Build Great Partnerships with Cell & Gene Therapy Companies
16 Jun, 2021
Industry Articles
by Ian Hamilton-Burge, Director of Customer Solutions

During our ongoing conversations with clients here at Zymewire, it became clear that cell and gene therapy companies were really heating up ...

Read More
Discovering Stealth Companies: Neuway Pharma from Bonn, Germany
Discovering Stealth Companies: Neuway Pharma from Bonn, Germany
16 Jun, 2021
Industry Articles
by Sara El-Talmas, Zymewire

We’re looking at Neuway Pharma, a Europe-based biotech startup, in this edition of Sponsor Atlas series. This branch of the blog focuses on ...

Read More
Selling to Biotech After the COVID Cliff
Selling to Biotech After the COVID Cliff
14 May, 2021
Zymewire News
by Casey Enders

Are you wondering how the pandemic will change the biotech landscape and your prospecting work? We were, too – so we dug into the data and ...

Read More
Discovering Biotech Startups: A map for Selling to Vanguard Therapeutics
Discovering Biotech Startups: A map for Selling to Vanguard Therapeutics
08 Dec, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Canget BioTekpharma: A One Pager for Selling to this Stealth Biotech Startup
Canget BioTekpharma: A One Pager for Selling to this Stealth Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Braizon Therapeutics: A Map for Selling to this Japanese Stealth Biotech Startup
Braizon Therapeutics: A Map for Selling to this Japanese Stealth Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

In this edition of Sponsor Atlas: Discovering Biotech Startups, we’re looking at Braizon Therapeutics (Braizon). We will give a business ...

Read More
Mekanistic Therapeutics: A Map for Selling to this Stealth Biotech Startup
Mekanistic Therapeutics: A Map for Selling to this Stealth Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Sulfateq BV: A Map for Selling to this European Biotech Startup
Sulfateq BV: A Map for Selling to this European Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

In this edition of Sponsor Atlas: Discovering Biotech Startups, we are looking at Sulfateq BV (Sulfateq), exploring the current affairs and ...

Read More
Montisera: A Map for selling to this emerging European Biotech
Montisera: A Map for selling to this emerging European Biotech
08 Dec, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Tiburio Therapeutics: A Map for Selling to this Stealth Biotech Startup
Tiburio Therapeutics: A Map for Selling to this Stealth Biotech Startup
21 Oct, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
CPhI Festival of Pharma
CPhI Festival of Pharma
01 Oct, 2020
Racolta
by Amarpreet Singh

After many discussions with key partners and industry stakeholders, the annual CPhI Worldwide (in-person) event is now confirmed to return ...

Read More
All About AbbVie: A map for Selling to AbbVie
All About AbbVie: A map for Selling to AbbVie
30 Sep, 2020
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Discovering Biotech Startups: A map for Selling to Geneos Therapeutics
Discovering Biotech Startups: A map for Selling to Geneos Therapeutics
16 Sep, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Blueprint to Biogen: A map for Selling to Biogen
Blueprint to Biogen: A map for Selling to Biogen
08 Sep, 2020
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Discovering Biotech Startups: A map for Selling to Pyxis Oncology
Discovering Biotech Startups: A map for Selling to Pyxis Oncology
01 Sep, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Felix Biotechnology
Discovering Biotech Startups: A map for Selling to Felix Biotechnology
01 Sep, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Sales Intelligence Products: Things to Consider for Your Team
Sales Intelligence Products: Things to Consider for Your Team
31 Aug, 2020
Industry Articles
by Sean Cannon

In today’s world, many providers are claiming to be sales intelligence solutions. This statement is remarkably convoluted, as the category ...

Read More
Twentyeight-Seven Therapeutics: A One Pager for Selling to this Stealth Biotech Startup
Twentyeight-Seven Therapeutics: A One Pager for Selling to this Stealth Biotech Startup
17 Aug, 2020
Industry Articles
by Amarpreet Singh

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A Map for Selling to NanoCell Therapeutics
Discovering Biotech Startups: A Map for Selling to NanoCell Therapeutics
23 Jun, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Symbiotica
Discovering Biotech Startups: A map for Selling to Symbiotica
23 Jun, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
DIA Global Annual Meeting 2020
DIA Global Annual Meeting 2020
12 Jun, 2020
Racolta
by David Wilkerson

In light of the recent pandemic that has spread throughout the world, it is with great excitement to know that much of the invaluable ...

Read More
Discovering Biotech Startups: A map for Selling to Snap Bio
Discovering Biotech Startups: A map for Selling to Snap Bio
03 Jun, 2020
Industry Articles
by David Wilkerson

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Discovering Biotech Startups: A map for Selling to Intrepida Bio
Discovering Biotech Startups: A map for Selling to Intrepida Bio
03 Jun, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Alaya Bioscience
Discovering Biotech Startups: A map for Selling to Alaya Bioscience
03 Apr, 2020
Industry Articles
by David Wilkerson

We are moving right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology ...

Read More
Discovering Biotech Startups: A map for Selling to Avenzoar Pharmaceuticals
Discovering Biotech Startups: A map for Selling to Avenzoar Pharmaceuticals
03 Apr, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
What do big pharma companies spend on research & development?
What do big pharma companies spend on research & development?
01 Apr, 2020
Zymewire News
by Sean Cannon

We've been working hard on a new report, and today we're happy to share that it is now available through Outsourcing-Pharma! Our inaugural ...

Read More
Zymewire Launches Directory of Drug Development Experts with Services Available to Fight COVID-19
Zymewire Launches Directory of Drug Development Experts with Services Available to Fight COVID-19
01 Apr, 2020
Company News
by Team Zymewire

In these unprecedented times, the Zymewire team has been thinking deeply about ways in which we can contribute to the global fight against ...

Read More

Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads. Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.

Demo Zymewire
zymewire-inverted

©2023 Zymewire Logo Trademark of Zymewire, a Division of Lumerate Inc. All rights reserved. Salesforce, Sales Cloud, and others are trademarks of salesforce.com, Inc. and are used here with permission.